资源描述：
《穴位埋线对肥胖型多囊卵巢综合征患者性激素水平、胰岛素抵抗的影响》由会员上传分享，免费在线阅读，更多相关内容在学术论文-天天文库。
1、EffectsofAcupointCatgut-embeddingTherapyonHyperandrogenismandInsulinResistanceofObesePatientswithPolycysticOvarySyndromeSpecialty:AcupunctureandMoxibustionAuthor:KangChunJingTutor:Prof.ZhangTongAbstractObjective:Todiscusstheclinicalefficacyofacupointcatgut-embeddingtherapyofoboesePCOS.Toobservethee
2、ffectonhyperandrogenismandinsulinresistanceofobesePCOS,andtoinvestigatethetherapeuticmechanism.Methods:60casesofobesePCOSwererandomlydividedintotwogroups:theacupointcatgut-embeddinggroupandtheelectro-acupuncturegroup,30casesineachgroup.Toevaluatepatients’BMI,waistline,hisutism,acnescores,menstruala
3、bnormalities,LH,FSH,LH/FSH,T,FBG,FINSandHOMA-IRbeforeandafter3monthstreatment.Results:1.After3monthstreatment,BMI,waistline,hisutismandacnescoresweresignificantlyreduced(P<0.05)inbothgroups.Therewasnosignificantdifferencebetweentwogroups(P>0.05).2.After3monthstreatment,themenstrualabnormalities,his
4、utism,acnescores,LH,FSH,LH/FSH,Tweresignificantlyreduced(P<0.05)inbothgroups.Therewasnosignificantdifferencebetweentwogroups(P>0.05).TherewassignificantdifferenceinTlevelreductionbetweentwogroups(P<0.05).3.FBG,FINS,HOMA-IRweresignificantlyreduced(P<0.05)after3monthstreatmentinbothgroup.Therewasnosi
5、gnificantdifferencebetweentwogroups(P>0.05),buttherewassignificantdifferenceinFINSlevel(P<0.05)betweentwogroups.Conclusions:Acupointcatgut-embeddingtherapyisoneoftheeffectivemethodstotreatobesePCOS.Inclinicalpractice,acupointcatgut-embeddingtherapyisconvenientoperation,andhasalowcost.Soitworthwidel
6、yclinicalusing.KeyWordsPolycysticOvarySyndrome;Acupointcatgut-embeddingtherapy;Obesity目录引言...............................................................................................................................1临床研究.............................................................................
7、..................................................21研究对象............................................................................................................................21.1受试者来源.................
